Alison G Paquette1, Tianjiao Chu2, Xiaogang Wu1, Kai Wang1, Nathan D Price1, Yoel Sadovsky3. 1. Institute for Systems Biology, Seattle, WA, 98119, USA. 2. Magee-Womens Research Institute, USA; Department of Obstetrics and Gynecology and Reproductive Science, University of Pittsburgh, Pittsburgh, PA, 15213, USA. 3. Magee-Womens Research Institute, USA; Department of Obstetrics and Gynecology and Reproductive Science, University of Pittsburgh, Pittsburgh, PA, 15213, USA; Department of Microbiology and Molecular Genetics, University of Pittsburgh, Pittsburgh, PA, 15213, USA. Electronic address: ysadovsky@mwri.magee.edu.
Abstract
INTRODUCTION: The placenta produces microRNAs (miRNA) that may traffic to the maternal or fetal compartments and influence the physiology of pregnancy. The trafficking patterns of miRNA expressed from the large human chromosome 19 and chromosome 14 clusters (C19MC and C14MC), remains unclear. We interrogated the cross-sectional landscape of miRNA expression within the human placenta, fetal and maternal plasma to elucidate miRNA trafficking. We hypothesized that C19MC and C14MC miRNAs have similar expression patterns across the maternal-fetal compartments. METHODS: Placental biopsies, maternal and fetal venous plasma were collected from 25 pregnancies, and RNA was quantified using next generation sequencing. We identified expression and correlations differences among the compartments, and uncovered distinct miRNA expression patterns using consensus clustering. RESULTS: We found that the placenta exhibits the highest total abundance, average miRNA expression and lowest variance of both C19MC and C14MC miRNAs. The C19MC miRNAs had a comparable expression and variance in fetal and maternal plasma and higher expression in the placenta. In contrast, the C14MC miRNAs had comparable expression between the placenta and fetal plasma, which was higher than the maternal plasma. We also identified 5 distinct groups of trophoblastic miRNAs with different expression patterns in each compartment. DISCUSSION: This is the first comprehensive analysis of C19MC and C14MC miRNA expression patterns in the human placental, maternal and fetal compartments. Our findings suggest that C14MC miRNAs are produced by both the fetus and placenta, but C19MC miRNAs are produced primarily in the placenta and are trafficked to the fetal and maternal compartments.
INTRODUCTION: The placenta produces microRNAs (miRNA) that may traffic to the maternal or fetal compartments and influence the physiology of pregnancy. The trafficking patterns of miRNA expressed from the large human chromosome 19 and chromosome 14 clusters (C19MC and C14MC), remains unclear. We interrogated the cross-sectional landscape of miRNA expression within the human placenta, fetal and maternal plasma to elucidate miRNA trafficking. We hypothesized that C19MC and C14MC miRNAs have similar expression patterns across the maternal-fetal compartments. METHODS: Placental biopsies, maternal and fetal venous plasma were collected from 25 pregnancies, and RNA was quantified using next generation sequencing. We identified expression and correlations differences among the compartments, and uncovered distinct miRNA expression patterns using consensus clustering. RESULTS: We found that the placenta exhibits the highest total abundance, average miRNA expression and lowest variance of both C19MC and C14MC miRNAs. The C19MC miRNAs had a comparable expression and variance in fetal and maternal plasma and higher expression in the placenta. In contrast, the C14MC miRNAs had comparable expression between the placenta and fetal plasma, which was higher than the maternal plasma. We also identified 5 distinct groups of trophoblastic miRNAs with different expression patterns in each compartment. DISCUSSION: This is the first comprehensive analysis of C19MC and C14MC miRNA expression patterns in the human placental, maternal and fetal compartments. Our findings suggest that C14MC miRNAs are produced by both the fetus and placenta, but C19MC miRNAs are produced primarily in the placenta and are trafficked to the fetal and maternal compartments.
Authors: Andrew B Sparks; Eric T Wang; Craig A Struble; Wade Barrett; Renee Stokowski; Celeste McBride; Jacob Zahn; Kevin Lee; Naiping Shen; Jigna Doshi; Michel Sun; Jill Garrison; Jay Sandler; Desiree Hollemon; Patrick Pattee; Aoy Tomita-Mitchell; Michael Mitchell; John Stuelpnagel; Ken Song; Arnold Oliphant Journal: Prenat Diagn Date: 2012-01-06 Impact factor: 3.050
Authors: Shannon Fallen; David Baxter; Xiaogang Wu; Taek-Kyun Kim; Oksana Shynlova; Min Young Lee; Kelsey Scherler; Stephen Lye; Leroy Hood; Kai Wang Journal: J Cell Mol Med Date: 2018-03-08 Impact factor: 5.310
Authors: T Rajendra Kumar; Jane E B Reusch; Wendy M Kohrt; Judith G Regensteiner Journal: J Womens Health (Larchmt) Date: 2020-05-17 Impact factor: 2.681
Authors: Tania L Gonzalez; Laura E Eisman; Nikhil V Joshi; Amy E Flowers; Di Wu; Yizhou Wang; Chintda Santiskulvong; Jie Tang; Rae A Buttle; Erica Sauro; Ekaterina L Clark; Rosemarie DiPentino; Caroline A Jefferies; Jessica L Chan; Yayu Lin; Yazhen Zhu; Yalda Afshar; Hsian-Rong Tseng; Kent Taylor; John Williams; Margareta D Pisarska Journal: Epigenomics Date: 2021-05-25 Impact factor: 4.778
Authors: Alison G Paquette; Oksana Shynlova; Xiaogang Wu; Mark Kibschull; Kai Wang; Nathan D Price; Stephen J Lye Journal: J Cell Mol Med Date: 2019-07-24 Impact factor: 5.310